1. Yazici Y. Management of Behçet syndrome. Curr Opin Rheumatol. 2020;32(1):35–40. https://doi.org/10.1097/BOR.0000000000000666. (PMID: 31609785).
2. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2020: Behçet’s syndrome. Clin Exp Rheumatol. 2020;38(5 Suppl 127):3–10 (Epub 2020 Dec 10 PMID: 33331271).
3. Talarico R, Palagini L, Elefante E, Ferro F, Tani C, Gemignani A, Bombardieri S, Mosca M. Behçet’s syndrome and psychiatric involvement: is it a primary or secondary feature of the disease? Clin Exp Rheumatol. 2018;36(6 Suupl 115):125–8 (Epub 2018 Dec 13 PMID: 30582513).
4. Talarico R, Palagini L, d’Ascanio A, Elefante E, Ferrari C, Stagnaro C, Tani C, Gemignani A, Mauri M, Bombardieri S, Mosca M. Epidemiology and management of neuropsychiatric disorders in Behçet’s syndrome. CNS Drugs. 2015;29(3):189–96. https://doi.org/10.1007/s40263-015-0228-0. (PMID: 25643894).
5. Senusi AA, Ola D, Mather J, Mather J, Fortune F. Behçet’s syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status. Clin Exp Rheumatol. 2017;35(6 Suppl 108):43–50 (Epub 2017 Jun 8 PMID: 28598773).